JAUNDICE Symptoms and Causes

Jaundice causes your skin and the whites of your eyes to turn yellow. Too much bilirubin causes Jaundice. Bilirubin is a yellow chemical in hemoglobin, the substance that carries oxygen in your red blood cells. As red blood cells break down, your body builds new cells to replace them. The old ones are processed by the liver. If the liver cannot handle the blood cells as they break down, bilirubin builds up in the body and your skin may look yellow.

Many healthy babies have some Jaundice during the first week of life. It usually goes away. However, Jaundice can happen at any age and may be a sign of a problem. Jaundice can happen for many reasons, such as

  • Blood diseases
  • Genetic syndromes
  • Liver diseases, such as hepatitis or cirrhosis
  • Blockage of bile ducts
  • Infections
  • Medicines

Check out the latest treatments for JAUNDICE

JAUNDICE treatment research studies

RIBASPHERE clinical trials, surveys and public health registries

Find Drug Side Effect reports


Fatigue (131)
Anaemia (129)
Depression (100)
Asthenia (95)
Dyspnoea (84)
Nausea (82)
Dizziness (67)
White Blood Cell Count Decreased (63)
Dehydration (62)
Headache (58)
Diarrhoea (53)
Vomiting (52)
Weight Decreased (51)
Anxiety (49)
Alopecia (49)
Insomnia (46)
Condition Aggravated (43)
Platelet Count Decreased (35)
Anger (34)
Chest Pain (34)
Arthralgia (34)
Haemoglobin Decreased (33)
Decreased Appetite (33)
Influenza Like Illness (31)
Pneumonia (30)
Red Blood Cell Count Decreased (29)
Pain (29)
Loss Of Consciousness (29)
Back Pain (28)
Anorexia (27)
Chills (26)
Rash (25)
Fall (25)
Blood Glucose Increased (25)
Crying (25)
Cough (24)
Suicidal Ideation (22)
Pyrexia (21)
Abdominal Pain (21)
Hypertension (21)
Feeling Abnormal (20)
Abdominal Pain Upper (19)
Disturbance In Attention (19)
Blood Potassium Decreased (19)
Irritability (17)
Pregnancy (16)
Confusional State (16)
Paranoia (16)
Myalgia (15)
Pruritus (15)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

After 36 hrs fom taking Tamiflu for the flu I have slight yellowing of skin and eyes. When should I be concerned?

Bounching of walls,can't walk straight.slerered speach,despression, ieritable

Hi i had tested billrubin total at 03-10-2010 is 1.13 & i had tested again 18-10-2010 its below .88mg, then 23-11-2010 again tedted its 89 mg then its i m fit , now i its going to six mounth , now m i fit , at this time can i enjoy

Hi i hv jaundise suffering frm 10 dys cn i smoke.........???


If i was born with jaundiced! does this increase the chance of my liver to fail in the future?

Im worried about my partner, he has been drinking for a number of years and his eyes have a tinge of yellow, does this indicate he has liver disease.

Is it k to smoke when having jaundice?????????

My sisters baby had jaundice and now the doctors says that it had effectedher brain what can we do now pl help

On 03-03-2010 i tested bilirubin and it was 1.7% & doctor prefered the udiliv 300 mg on 14-3-2010 agin i tested bilirubin & it was 1.2% doctor said to continue the tablet for more 15 days i want kn

<strong></strong>after duoloton intake i was diagonosed with fatty liver with s.g.p.t.746u/l &amp; jaundice alongwith cystic fimbrae which i had to operate out

A friend of mine. 31yrs of age has been suffering from AIHA(Auto Immuno Hemolysis) since last 8 yrs... She had suffered 2 attacks of severe jaundice, the last one in 2008.She has undergone blood transfusions 2-3 times in last 2 yrs. Her Hb

A recent problem with a gall stone blocking the bile duct left my liver compromised. Jaundice and antibiotics left me feeling exhausted. I have a sebaceous cyst on my back which has become inflamed and in infected after I bumped against a

After consuming myonal for two days, i suffer from jaundice... my bilirubin counts wer of the roof so as my ALP, and ALT count.. hmm...

Avelox taken in early March has caused me to have severe hepatitis. ALT and AST counts are in the thousands. Jaundice went away and bilirubin is normal now. All scans were negative, but a liver biopsy showed scarring and inflamation. ALT and AST star

Decrease in energy levels, severe weakness, and then ended up with liver failure and jaundice. Was hospitalized for over two weeks and a liver biopsy done. At one point, they thought I had a tumor but in the end, it was a result o


I am taking mexium 20 mg regularly for last 1.5 years. Recent blood test have shown high level of liver enzymes . I am a non drinker and have never had any jaundice or any immunisation of hepatitis. Nexium definately messed up my healthy liver

I took clavulin for 7 days at the beginning of Sept. On Oct. 3 I became itchy from head to toe. Bloodwork showed that my liver enzymes were all elevated.I developed jaundice . I am very tired and have no energy and have missed three weeks of work wit

Is it k to smoke when having jaundice?????????

JAUNDICE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Implementation of a Transcutaneous Bilirubinometer
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Interventions: Device: Transcutaneous Bilirubinometer;   Other: visual assessment of neonatal Jaundice
Outcome Measures: Number of blood tests for bilirubin measurement (Before the potential start of phototherapy).;   Phototherapy duration in hours;   Number of serum bilirubin-values above the 'exchange transfusion limit';   Highest measured serum bilirubin-value;   Cost-effectiveness;   Number of patients having kernicterus
2 Recruiting Immune Function in Patients With Obstructive Jaundice
Conditions: Obstructive Jaundice;   Disease as Reason for ERCP;   Immune Dysfunction;   Immune Tolerance
Outcome Measures: Change in monocyte cytokine responses to endotoxin stimulation;   Change in concentration of systemic quorum sensing signaling molecules
3 Not yet recruiting The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice
Condition: Obstructive Jaundice
Intervention: Drug: Ursodeoxycholic Acid
Outcome Measures: Liver functional restoration;   To assess that in which functional parameters of the liver, treatment with UDCA will have greater impact
4 Recruiting Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates
Condition: Jaundice, Neonatal
Interventions: Procedure: Window tinting film for filtered sunlight phototherapy;   Device: conventional phototherapy
Outcome Measures: Change in Serum Bilirubin;   Incidence of Sunburn and Dehydration;   Non-inferiority of sunlight phototherapy;   Number of participants requiring intervention such as exchange blood transfusion
5 Unknown  Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice
Condition: Biliary Obstruction
Intervention: Device: SEMS
Outcome Measures: Overall cost comparison of metal versus plastic stent in patients with limited life expectancy;   Quality of life assessment
6 Recruiting Quality of Life After BDA or Stents to Treat Biliary Obstruction in Pancreas Cancer
Conditions: Local Tumor Spread;   Advanced Cancer;   Metastasized;   Pancreatic Cancer Non-resectable;   Jaundice
Interventions: Procedure: Stent;   Procedure: Biliodigestive anastomosis
Outcome Measures: Outcome of Quality of Life.;   The incidence of surgical complications and complications, with regard to the endo-scopic stent insertion, are further aspects that shall be examined in this study.
7 Unknown  Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice
Condition: Biliary Atresia
Outcome Measure:
8 Recruiting Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
Conditions: Periampullary Cancers Causing Obstructive Jaundice;   Pancreas Head Cancer;   Bile Duct Cancer;   Ampulla of Vater Cancer
Intervention: Procedure: biliary drainage
Outcome Measures: Incidence of infectious complications after biliary drainage;   Effect of reducing serum total bilirubin after drainage;   Peritumoral inflammatory reaction after drainage;   Fibrosis of the bile duct;   Difficulties in dissection around the tumor
9 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
Outcome Measures: Percent change from baseline in total serum bilirubin (TSB) (the baseline TSB is the TSB that qualifies for randomization) at 48 hours post-dose;   Percent change from baseline in TSB (the baseline TSB is the TSB that qualifies for randomization) at 6, 12, 24, and 36 hours;   Total serum bilirubin area under the curve (AUC) above the baseline TSB (0 to 48 hours post-dose).;   Peak serum bilirubin;   Incidence of rebound hyperbilirubinemia defined as an increase in TSB above the age-specific threshold for initiating PT per the AAP Guidelines (AAP) following the discontinuation of the initial PT;   Incidence of readmission to hospital for hyperbilirubinemia due to a TSB at or above the age specific threshold for PT;   Duration of clinical requirement for PT;   Incidence of adverse events (AE) and serious adverse events (SAE's);   Changes in vital sign measurements;   Results of physical exam (PE), including growth measurements;   Results of neurologic exam, including eye and hearing assessment;   Electrocardiographic (ECG) assessments;   Clinical laboratory tests including hematology, serum chemistries, liver function and renal function tests
10 Unknown  Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Conditions: ABO Incompatibility;   Hemolytic Disease of Newborn;   Neonatal Jaundice;   Neonatal Hyperbilirubinemia
Outcome Measure:
11 Recruiting Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
Conditions: Obstructive Jaundice;   Pancreatic Cancer
Interventions: Procedure: Metal stent placement in the bile duct;   Procedure: Plastic stent
Outcome Measures: Complications related to stent dysfunction;   Procedural complications
12 Recruiting Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
Condition: Jaundice
Interventions: Device: biliary drainage;   Device: EUS guided biliary drainage
Outcome Measures: Morbidity rate;   efficacy;   feasibility;   biliary drainage duration;   quality of life
13 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
Outcome Measure:
14 Recruiting Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Conditions: Stroke;   Rhabdomyolysis;   Jaundice
Interventions: Drug: Lovastatin;   Other: Placebo
Outcome Measures: Increase in Liver Function Tests (LFTs);   Increase in Creatine Kinase (CK);   Score on NIH Stroke Scale;   Barthel Index Score;   Modified Rankin scores
15 Recruiting ComVi Stent Versus Uncovered Self-Expandable Metal Stent (SEMS) for Biliary SEMS Occlusion
Conditions: Biliary Tract Neoplasms;   Jaundice, Obstructive
Interventions: Device: ComVi stent;   Device: Uncovered SEMS
Outcome Measure: Time to stent occlusion
16 Unknown  Acute Viral Hepatitis and Diabetes Mellitus
Conditions: Acute Viral Hepatitis;   Diabetes Mellitus
Outcome Measures: Duration of icteric hepatitis.;   Development of complications;   Mortality
17 Recruiting Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
Conditions: Periampullary Cancer;   Pancreatic Cancer
Interventions: Procedure: Endoscopic stenting;   Procedure: cholecystojejunostomy
Outcome Measures: Technical success;   Successful drainage;   Procedure-related complication: was defined complications directly related to stent insertion/CJ;   Intraoperative assessment;   1. Procedure-related mortality;   2. Duration of hospital stay;   3. Postoperative complication:;   a. Wound infection;   b. Intra-abdominal abscess;   c. Postoperative haemorrhage;   d. Pancreaticojejunal leak;   e. Bile leak
18 Unknown  Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction
Conditions: Bile Duct Neoplasm;   Obstructive Jaundice
Interventions: Procedure: parallel stent;   Device: Y-stent (BONASTENT M-Hilar)
Outcome Measure: The time taken to insert bilateral stent
19 Recruiting Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression
Conditions: Obstructive Jaundice;   Pancreatic Cancer
Interventions: Procedure: Stent Dysfunction;   Procedure: Complications
Outcome Measures: Complications related to stent dysfunction;   Procedural complications
20 Unknown  Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
Conditions: Respiratory Distress;   Hypoglycemia;   Feeding Intolerance;   Jaundice;   Hypothermia;   Developmental Delay
Outcome Measure: neurodevelopmental, health and growth status in late preterm infants vs. controls within the first year of life